Cargando…
Surgical antibiotic prophylaxis administration practices
SETTING: A referral hospital in Kavre, Nepal. OBJECTIVES: To assess 1) compliance with National Antibiotic Treatment Guidelines (NATG), specifically, whether the administration of surgical antibiotic prophylaxis (SAP) (initial dosing and redosing) was in compliance with NATG for patients who were an...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union Against Tuberculosis and Lung Disease
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575384/ https://www.ncbi.nlm.nih.gov/pubmed/34778011 http://dx.doi.org/10.5588/pha.21.0027 |
_version_ | 1784595670155395072 |
---|---|
author | Shrestha, S. Hann, K. Kyaw, K. W. Y. Koju, P. Khogali, M. |
author_facet | Shrestha, S. Hann, K. Kyaw, K. W. Y. Koju, P. Khogali, M. |
author_sort | Shrestha, S. |
collection | PubMed |
description | SETTING: A referral hospital in Kavre, Nepal. OBJECTIVES: To assess 1) compliance with National Antibiotic Treatment Guidelines (NATG), specifically, whether the administration of surgical antibiotic prophylaxis (SAP) (initial dosing and redosing) was in compliance with NATG for patients who were and were not eligible, and 2) development of surgical site infections (SSIs) among patients who underwent surgery in the Department of General Surgery (July–December 2019). DESIGN: This was a retrospective cohort analysis. RESULTS: The analysis included 846 patients, of which 717 (85%) patients were eligible for SAP and 129 (15%) were ineligible. Of those eligible, 708 (99%) received the initial dose; while 65 (50%) of the ineligible did not receive any dose. Of those who received the initial dose, 164 (23%) were eligible for redosing. Of these, only 23 (14%) received at least one redosing and 141 (86%) did not receive it. Overall compliance with NATG was achieved in 75% (632/846) of patients. SSIs occurred in 23 (3%) patients, 8 (35%) of whom did not have SAP administered according to NATG. CONCLUSION: A relatively high overall compliance with NATG for SAP administration was reported. Recommendations were made to improve compliance among those who were ineligible for SAP and those who were eligible for redosing. |
format | Online Article Text |
id | pubmed-8575384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | International Union Against Tuberculosis and Lung Disease |
record_format | MEDLINE/PubMed |
spelling | pubmed-85753842021-11-13 Surgical antibiotic prophylaxis administration practices Shrestha, S. Hann, K. Kyaw, K. W. Y. Koju, P. Khogali, M. Public Health Action Amr Supplement SETTING: A referral hospital in Kavre, Nepal. OBJECTIVES: To assess 1) compliance with National Antibiotic Treatment Guidelines (NATG), specifically, whether the administration of surgical antibiotic prophylaxis (SAP) (initial dosing and redosing) was in compliance with NATG for patients who were and were not eligible, and 2) development of surgical site infections (SSIs) among patients who underwent surgery in the Department of General Surgery (July–December 2019). DESIGN: This was a retrospective cohort analysis. RESULTS: The analysis included 846 patients, of which 717 (85%) patients were eligible for SAP and 129 (15%) were ineligible. Of those eligible, 708 (99%) received the initial dose; while 65 (50%) of the ineligible did not receive any dose. Of those who received the initial dose, 164 (23%) were eligible for redosing. Of these, only 23 (14%) received at least one redosing and 141 (86%) did not receive it. Overall compliance with NATG was achieved in 75% (632/846) of patients. SSIs occurred in 23 (3%) patients, 8 (35%) of whom did not have SAP administered according to NATG. CONCLUSION: A relatively high overall compliance with NATG for SAP administration was reported. Recommendations were made to improve compliance among those who were ineligible for SAP and those who were eligible for redosing. International Union Against Tuberculosis and Lung Disease 2021-11-01 2021-11-01 /pmc/articles/PMC8575384/ /pubmed/34778011 http://dx.doi.org/10.5588/pha.21.0027 Text en © 2021 The Union https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence CC-BY 4.0 (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ) published by The Union (www.theunion.org (http://www.theunion.org) ). |
spellingShingle | Amr Supplement Shrestha, S. Hann, K. Kyaw, K. W. Y. Koju, P. Khogali, M. Surgical antibiotic prophylaxis administration practices |
title | Surgical antibiotic prophylaxis administration practices |
title_full | Surgical antibiotic prophylaxis administration practices |
title_fullStr | Surgical antibiotic prophylaxis administration practices |
title_full_unstemmed | Surgical antibiotic prophylaxis administration practices |
title_short | Surgical antibiotic prophylaxis administration practices |
title_sort | surgical antibiotic prophylaxis administration practices |
topic | Amr Supplement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575384/ https://www.ncbi.nlm.nih.gov/pubmed/34778011 http://dx.doi.org/10.5588/pha.21.0027 |
work_keys_str_mv | AT shresthas surgicalantibioticprophylaxisadministrationpractices AT hannk surgicalantibioticprophylaxisadministrationpractices AT kyawkwy surgicalantibioticprophylaxisadministrationpractices AT kojup surgicalantibioticprophylaxisadministrationpractices AT khogalim surgicalantibioticprophylaxisadministrationpractices |